Stratistics MRC에 따르면 세계 산소요법 장비 시장은 2024년 48억 달러를 차지하며, 예측 기간 동안 CAGR 9.5%로 성장하며 2030년에는 82억 달러에 이를 것으로 예상됩니다.
산소 요법 장비는 COPD, 천식, 저산소혈증과 같은 호흡기 질환을 가진 사람들에게 보조 산소를 공급하도록 설계된 장비로 구성됩니다. 코 캐뉼라, 마스크, 휴대용 산소 시스템 등이 있으며 가정용, 병원용, 외래용으로 조정되어 있습니다.
CDC에 따르면 미국에서는 약 1,600만 명의 성인이 만성 폐색성 폐질환(COPD)을 앓고 있습니다.
만성 호흡기 질환 증가
COPD, 천식, 폐 섬유증과 같은 만성 호흡기 질환의 유병률 증가는 산소 요법 장비 시장의 주요 촉진요인입니다. 많은 환자에게 장기적인 산소 요법이 필요합니다. 이 수요는 산소 요법의 장점과 삶의 질을 향상시키는 역할에 대한 의식 증가에 의해 더욱 확대되고 있습니다.
장비의 높은 비용
첨단 산소 요법 장비와 관련된 높은 비용은 시장 성장의 주요 억제요인이되었습니다. 경제적 부담은 건강 관리 제공업체입니다. 최신 기술에 대한 투자 능력에 영향을 미치고 효과적인 호흡 관리 솔루션에 대한 액세스를 제한 할 수 있습니다. 중요한 문제인 신흥 국가에서는 시장 개척의 방해가 됩니다.
홈 헬스케어 서비스 확대
재택 건강 서비스의 확대는 산소 요법 장비 시장에서 큰 기회입니다. 이 동향은 장비의 휴대성과 사용 편의성을 높이는 기술의 진보에 의해 지원되고 있습니다.
복잡한 규제 요건
복잡한 규제 요건은 산소 요법 장비 시장의 위협이 되고 있습니다. 이 규정은 안전과 효과를 보장하지만 제품 출시를 지연시키고 개발 비용을 증가시킬 수 있습니다.
COVID-19의 대유행은 환자의 호흡기 합병증 증가로 산소 치료 장비 수요를 크게 밀어 올렸습니다., 병원과 재택 개호 모두의 환경에서의 채용을 가속시켰습니다.
예측기간 동안 산소원 장비 분야가 최대가 될 전망
산소원장비 분야는 다양한 환경에서 산소요법을 실시하는데 있어서 필수적인 역할을 하기 때문에 예측기간 중에 최대 시장 점유율을 차지할 것으로 보입니다. 치료와 집에서의 장기 관리 모두에 필수적인 농축기, 실린더, 액체 시스템이 포함되어 있습니다.
예측 기간 동안 휴대용 장비 분야의 CAGR이 가장 높아질 전망
예측 기간 동안 휴대용 장비 분야가 가장 높은 CAGR을 나타낼 것으로 예상됩니다. 성과 유연성을 제공하기 위해 환자는 필요한 치료를 받으면서 라이프 스타일을 유지할 수 있습니다.
북미는 헬스케어 인프라가 발달하고 있어 COPD나 천식 등의 호흡기 질환의 유병률이 높기 때문에 예측 기간 중에 최대 시장 점유율을 차지할 것으로 예상됩니다. 헬스케어 지출이 이 우위성을 한층 더 지지하고 있습니다.또, 주요 제조업체의 존재도 북미 시장 점유율을 크게 밀어 올리고 있습니다.
아시아태평양은 호흡 케어에 대한 의식이 높아지고 정부의 지원책으로 예측 기간 동안 가장 높은 성장률을 나타낼 것으로 예측되고 있습니다. 첨단 의료장비에 대한 수요가 높아짐에 따라, 아시아태평양은 세계 시장에서 중요한 성장 지역으로서 부상하고 있습니다.
According to Stratistics MRC, the Global Oxygen Therapy Equipment Market is accounted for $4.8 billion in 2024 and is expected to reach $8.2 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Oxygen therapy equipment comprises devices designed to deliver supplemental oxygen to individuals with respiratory conditions such as COPD, asthma, or hypoxemia. Key components include oxygen concentrators, cylinders, nasal cannulas, masks, and portable oxygen systems, tailored for home, hospital, or ambulatory use. These devices ensure optimal oxygen delivery to improve breathing efficiency, enhance oxygen saturation levels, and support critical medical conditions.
According to the CDC, nearly 16 million adults in the United States have chronic obstructive pulmonary disease (COPD).
Rise in chronic respiratory conditions
The increasing prevalence of chronic respiratory conditions such as COPD, asthma, and pulmonary fibrosis is a major driver for the oxygen therapy equipment market. Factors like air pollution, smoking, and an aging population contribute to these conditions, necessitating long-term oxygen therapy for many patients. This demand is further amplified by the growing awareness of oxygen therapy's benefits and its role in improving quality of life. As these respiratory issues continue to rise globally, the market for oxygen therapy equipment is expected to expand significantly.
High costs of equipment
High costs associated with advanced oxygen therapy equipment are a significant restraint on market growth. These costs can be prohibitive for many patients, especially in low-income regions or for those without comprehensive insurance coverage. The financial burden also affects healthcare providers' ability to invest in the latest technologies, potentially limiting access to effective respiratory care solutions. This cost barrier can lead to disparities in treatment quality and hinder market expansion, particularly in developing countries where affordability is a critical concern.
Expansion of home healthcare services
The expansion of home healthcare services presents a significant opportunity for the oxygen therapy equipment market. With a growing preference for home-based care, particularly among the elderly and those with chronic conditions, demand for portable and user-friendly oxygen devices is increasing. This trend is supported by technological advancements that enhance device portability and ease of use. As more patients opt for home-based treatments to maintain independence and comfort, the market for home-use oxygen therapy equipment is poised for substantial growth.
Complex regulatory requirements
Complex regulatory requirements pose a threat to the oxygen therapy equipment market. Compliance with stringent standards set by bodies such as the FDA in the U.S. or CE marking in Europe is essential for market entry but can be challenging and costly for manufacturers. These regulations ensure safety and efficacy but can delay product launches and increase development costs.
The COVID-19 pandemic significantly boosted the demand for oxygen therapy equipment due to increased respiratory complications among patients. The crisis highlighted the importance of accessible oxygen supplies, accelerating adoption in both hospital and homecare settings. This surge in demand led to rapid innovations and expansions within the market, setting a foundation for sustained growth even post-pandemic.
The oxygen source equipment segment is expected to be the largest during the forecast period
The oxygen source equipment segment is expected to account for the largest market share during the forecast period due to its essential role in delivering oxygen therapy across various settings. This segment includes concentrators, cylinders, and liquid systems that are vital for both acute care in hospitals and long-term management at home. Its dominance is driven by the rising incidence of respiratory diseases requiring consistent oxygen supply.
The portable devices segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the portable devices segment is expected to witness the highest CAGR. The increasing need for mobility among patients and advancements in portable technology drive this growth. Portable devices offer convenience and flexibility, enabling patients to maintain their lifestyle while receiving necessary therapy. As innovations continue to enhance portability and efficiency, this segment's rapid expansion is anticipated.
The North America region is anticipated to account for the largest market share during the forecast period due to its advanced healthcare infrastructure and high prevalence of respiratory diseases like COPD and asthma. Favorable reimbursement policies and significant healthcare expenditure further support this dominance. The presence of leading manufacturers also contributes to North America's substantial market share.
The Asia Pacific region is anticipated to register the highest growth rate over the forecast period due to increasing awareness about respiratory care and supportive government initiatives. The rising geriatric population and improving healthcare infrastructure in countries like China and India bolster this growth. As demand for advanced medical devices increases, Asia Pacific emerges as a key growth region in the global market landscape.
Key players in the market
Some of the key players in Oxygen Therapy Equipment Market include Koninklijke Philips N.V., ResMed Inc., Invacare Corporation, Fisher & Paykel Healthcare Corporation Limited, AirSep Corporation, Dragerwerk AG & Co. KGaA, GE Healthcare, Medtronic PLC, Smiths Medical, Teleflex Incorporated, Drive DeVilbiss Healthcare, Nidek Medical Products Inc., O2 Concepts LLC, Inogen Inc., Chart Industries, Taiyo Nippon Sanso Corporation, Vyaire Medical Inc. and Precision Medical Inc.
In November 2023, Fisher & Paykel Healthcare Corporation Limited announced today it has released the Airvo 3 high flow system, which builds upon the market-leading Airvo 2, offering more advanced technology and a broader range of features for oxygen therapy delivery.
In June 2023, Philips has announced that the SimplyGo Mini portable oxygen concentrator conforms to FAA standards, making it available for on-board aircraft use, providing a new option for chronic respiratory patients who are on-the-go.
In February 2023, React Health subsidiary Ventec Systems has acquired Invacare's respiratory assets, including various oxygen therapy products. "With this acquisition, React Health is well positioned to continue to support the end-to-end care of patients with cardiology, sleep and respiratory illnesses, in partnership with physicians and providers of diagnostic and needed therapies," said Tom Pontzius, president of operations for React Health.